secwatch.observer — SEC 8-K summary
======================================

Issuer:     Forte Biosciences, Inc. (FBRX)
CIK:        0001419041
Form:       8-K
Filed at:   2025-04-18T23:59:59+00:00
Accession:  0001193125-25-085762
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Forte Biosciences sets annual meeting for May 29, 2025; proposals due April 28
------------------------------------------------------------------------------

- Annual meeting scheduled for May 29, 2025, more than 30 days before the 2024 anniversary.
- Stockholder proposals for proxy inclusion must be received by April 28, 2025.
- Director nominations and other proposals (non-14a-8) due no later than April 28, 2025.
- Universal proxy rule compliance notices for soliciting support of non-company nominees due April 28, 2025.
- Prior deadlines for stockholder submissions are no longer applicable due to the revised meeting date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1419041/000119312525085762/0001193125-25-085762-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1419041/000119312525085762/d206139d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-085762

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer